Skip to main content
Clinical Trials/NCT01278290
NCT01278290CompletedPhase 3

Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls.

Hospital de Niños R. Gutierrez de Buenos Aires2 sites in 1 country46 target enrollmentStarted: December 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
46
Locations
2
Primary Endpoint
Estradiol

Study Overview

Brief Summary

The aim of the study is to determine the specificity, sensitivity and diagnostic efficiency of the Triptorelin Test in the assessment of CPP compared to GnRH test as gold standard.

Hypothesis: Aqueous Triptorelin Acetate is so efficient as GnRH to CPP assessment.

Study population are girls with suspicious clinical features of precocious puberty

Detailed Description

GnRH stimulation is the gold standard to distinguish between isolated premature thelarche (PT) and CPP. However, intravenous GnRH for testing is not fully available in all countries. To evaluate the diagnostic accuracy of a novel Triptorelin-test in the assessment of CPP compared to the GnRH test, a validation study was performed. Girls who presented thelarche with accelerated growth and/or advanced bone age were included. All girls underwent the two tests in a randomized order. CPP was ascertained according to LH response under GnRH (gold standard test).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
3 Years to 8 Years (Child)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • premature thelarche and/or
  • accelerated growth velocity (above 90 percentile)
  • advanced bone age at least 1.5 year in relation to chronological age.

Exclusion Criteria

  • contact with sources of exogenous estrogens in the last four months previous to evaluation,
  • suspicion of peripheral precocious puberty,
  • previous central nervous system illness or suspicion of organic central precocious puberty.

Outcomes

Primary Outcomes

Estradiol

Time Frame: 24 hs

Levels of Estradiol are measured at T 0 (before) and T 3 h y T 24 h (after) Triptorelin stimulation.

LH

Time Frame: 3 hs

Levels of LH are measured at T 0 (before) and T 3 h y T 24 h (after) Triptorelin stimulation.

Secondary Outcomes

  • FSH(3 hs)

Investigators

Sponsor
Hospital de Niños R. Gutierrez de Buenos Aires
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Analía Freire

Pediatric Endocrinology, PhD

Hospital de Niños R. Gutierrez de Buenos Aires

Study Sites (2)

Loading locations...

Similar Trials